RSA 318:16 · Special Permits

Source history

• 1921, 122:9. PL 210:16. RL 256:16. RSA 318:16
• 1981, 484:18, eff. July 1, 1981

Related materials

Bill relationships

• 2026 HB1249 reference

  rvices and Elderly Affairs ----------------------------------------------------------------- ANALYSIS This bill amends the definition of the practice of pharmacy under RSA 318 and authorizes pharmacists to prescribe certain prescription devices necessary for the appropriate delivery or administration of a prescribed drug. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

• 2026 HB1584 amend · effective 2027-01-01

  each operated at a surplus for the past year. In no case shall the commissioner make such certification prior to July 1, 2027. 9 New Subdivision; Drug Pricing Options. Amend RSA 318 by inserting after section 47-m the following new subdivision: Drug Pricing Options 318:47-n Notice of Drug Pricing Options. I. Every pharmacy licensed in this state shall make reasonable efforts to notify cons

• 2026 HB1584-FN amend · effective 2027-01-01

  each operated at a surplus for the past year. In no case shall the commissioner make such certification prior to July 1, 2027. 9 New Subdivision; Drug Pricing Options. Amend RSA 318 by inserting after section 47-m the following new subdivision: Drug Pricing Options 318:47-n Notice of Drug Pricing Options. I. Every pharmacy licensed in this state shall make reasonable efforts to notify cons

• 2026 HB194 amend · effective 2027-01-01

  of a collaborative pharmacy practice agreement, including influenza immunizations. [(b) Engage in collaborative pharmacy practices.] 9 Licensed Pharmacists; Standards for Collaborative Pharmacy Practice. Amend RSA 318:16-a, I(c) to read as follows: (c) Have the knowledge base necessary for proper monitoring, including, but not limited to, associated disease states, relevant laboratory tests, adverse events, drug and food interac

• 2026 HB194-FN reference · effective 2027-01-01

  medication therapy management; (5) The participation in collaborative pharmacy practice and collaborative pharmacy practice agreements as defined in RSA 318:1, XXVI - XXVII, and RSA 318:16-a; (6) The prescribing, ordering, administering, and interpretation of laboratory tests, controlled and noncontrolled drugs, and devices; (7) The education and counseling of patients and health care professionals on t

• 2026 SB504 amend · effective 2027-01-01

  ould be provided in a similar setting by a reasonable and prudent individual with similar education, training, and experience. 13 Pharmacist Administration of Vaccines. Amend RSA 318:16-b, II to read as follows: II. A pharmacist, pharmacy intern, [or] licensed advanced pharmacy technician, or certified pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer vacci

• 2026 SB504 reference · effective 2027-01-01

  medication therapy management; (5) The participation in collaborative pharmacy practice and collaborative pharmacy practice agreements as defined in RSA 318:1, XXVI - XXVII, and RSA 318:16-a; (6) The prescribing, ordering, administering, and interpretation of laboratory tests, controlled and noncontrolled drugs, and devices in accordance with applicable state and federal law; (7) The education and couns

• 2026 SB504 reference · effective 2027-01-01

  including rules to enforce the requirements of this section. V. Nothing in this section shall be construed to alter the jurisdiction or authority of the board of pharmacy under RSA 318. 126-ZZ:7 Free Care and Public Benefits. I. Each licensed experimental treatment center shall allocate 2 percent of its net annual profits to support access to experimental treatments and health care for qualifyin

• 2026 SB504-FN amend · effective 2027-01-01

  ould be provided in a similar setting by a reasonable and prudent individual with similar education, training, and experience. 13 Pharmacist Administration of Vaccines. Amend RSA 318:16-b, II to read as follows: II. A pharmacist, pharmacy intern, [or] licensed advanced pharmacy technician, or certified pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer vacci

• 2026 SB504-FN reference · effective 2027-01-01

  medication therapy management; (5) The participation in collaborative pharmacy practice and collaborative pharmacy practice agreements as defined in RSA 318:1, XXVI - XXVII, and RSA 318:16-a; (6) The prescribing, ordering, administering, and interpretation of laboratory tests, controlled and noncontrolled drugs, and devices in accordance with applicable state and federal law; (7) The education and couns

• 2026 SB504-FN reference · effective 2027-01-01

  including rules to enforce the requirements of this section. V. Nothing in this section shall be construed to alter the jurisdiction or authority of the board of pharmacy under RSA 318. 126-ZZ:7 Free Care and Public Benefits. I. Each licensed experimental treatment center shall allocate 2 percent of its net annual profits to support access to experimental treatments and health care for qualifyin

• 2026 SB665 amend · effective 2027-01-01

  s used to compensate the pharmacy benefits manager. VII. Nothing in this section shall prohibit the use of spread pricing. 13 New Subdivision; Drug Pricing Options. Amend RSA 318 by inserting after section 47-m the following new subdivision: Drug Pricing Options 318:47-n Notice of Drug Pricing Options. I. Every pharmacy licensed in this state shall make reasonable efforts to notify cons